Jul 27, 2020

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Interview with Dr Matulonis on the following topics:

• Perspective on the use of immune checkpoint inhibitor (ICI) therapy for patients with ovarian cancer...

Jul 27, 2020

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Interview with Dr Birrer on the following topics:

• Diagnosis and management of endometrial cancer with POLE mutation (00:00)
• Mechanism of action and tolerability...

Jul 27, 2020

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Interview with Dr Tewari on the following topic:

• Selection and sequencing of therapies for metastatic cervical cancer; mechanism of action, efficacy and tolerability of...

Jul 27, 2020

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Interview with Dr O’Malley on the following topics:

• Emerging efficacy and safety data with and ongoing investigation of tisotumab vedotin in the management of...

Jul 23, 2020

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Faculty Presentation 1: Current and Potential Role of Immune Checkpoint Inhibitor Therapy in Ovarian Cancer Management — Dr Matulonis
CME information and select...